No price history available.
Key financial summary
Financials in THB| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | THBm | 144,732 | 138,465 | 150,338 | 154,672 | 157,727 | 154,020 | N/A | N/A |
| Operating profit | THBm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net profit | THBm | 4,001 | 3,585 | 5,010 | 4,795 | 4,001 | 4,011 | N/A | N/A |
| EPS reported | THB | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating cashflow per share | THB | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Capex per share | THB | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF per share | THB | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Free cash flow | THBm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt | THBm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value equity | THBm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value per share | THB | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Number of shares | m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| DPS (TTM paid) | THB | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Financial summary
Financials in THB| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/B LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/S LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/FCF LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/EBITDA LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/Sales LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Earnings Yield LTM | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Quality | |||||||||
| ROE | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| ROIC | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Sales | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Growth and momentum | |||||||||
| EPS Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Sales Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Income Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating Profit Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend and capital structure | |||||||||
| Dividend Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Payout Ratio | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Debt | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Debt/EBITDA | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EBIT/Net interest | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/market cap | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/Equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross debt/equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
Berli Jucker Public Company Limited, established in 1882 and based in Bangkok, Thailand, operates as a diversified enterprise under the umbrella of TCC Corporation Company Limited. Its extensive operations in Thailand involve manufacturing, distribution, and a range of services across key sectors including packaging, consumer products, healthcare and technical solutions, modern retail supply chain management, and other business initiatives. The company specializes in the design, production, and commercialization of various packaging solutions, encompassing glass, plastic, and aluminum containers. Within its consumer goods division, BJC is a prominent distributor of popular personal care items, such as Cellox and Zilk tissues and toilet papers, Maxmo multi-purpose papers, Parrot soaps, and Dermapon baby soaps. Its snack offerings include Tasto potato chips, Dozo rice crackers, and Party and Campus extruded snacks. Beyond these, the portfolio extends to a wide array of food products like beverages, packaged fruits, dairy, and yogurt, as well as non-food essentials such as household goods, stationery, and office equipment. BJC’s healthcare and technical segment is dedicated to importing and distributing a comprehensive range of medical and health-related products. This includes pharmaceuticals for various diseases—covering kidney, hematological, cardiovascular, endocrine, genitourinary, skeletal, infectious, oncological, and pediatric conditions—along with medical supplies, cosmeceuticals, nutritional supplements, and beauty products. The company also provides advanced medical equipment, including computed radiography, ultrasound, digital mammography, X-ray, and 3D medical image processing systems, as well as laboratory information systems. Additionally, Berli Jucker engages in providing ingredients for the bakery, food, nutraceutical, and cosmetic sectors, alongside industrial chemicals and refrigerants. Its service capabilities are extensive, encompassing logistics management with warehousing, transportation, customs brokerage, and freight forwarding. The company also operates an e-commerce platform and offers consulting, design, installation, and post-sales support for industrial cranes, solar rooftop systems, and weighing control systems.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Berli Jucker Public Company Limited (BJC.BK)
No price history available.
Based on consensus from external analysts. Not Kvantra's opinion.
Berli Jucker Public Company Limited, established in 1882 and based in Bangkok, Thailand, operates as a diversified enterprise under the umbrella of TCC Corporation Company Limited. Its extensive operations in Thailand involve manufacturing, distribution, and a range of services across key sectors including packaging, consumer products, healthcare and technical solutions, modern retail supply chain management, and other business initiatives. The company specializes in the design, production, and commercialization of various packaging solutions, encompassing glass, plastic, and aluminum containers. Within its consumer goods division, BJC is a prominent distributor of popular personal care items, such as Cellox and Zilk tissues and toilet papers, Maxmo multi-purpose papers, Parrot soaps, and Dermapon baby soaps. Its snack offerings include Tasto potato chips, Dozo rice crackers, and Party and Campus extruded snacks. Beyond these, the portfolio extends to a wide array of food products like beverages, packaged fruits, dairy, and yogurt, as well as non-food essentials such as household goods, stationery, and office equipment. BJC’s healthcare and technical segment is dedicated to importing and distributing a comprehensive range of medical and health-related products. This includes pharmaceuticals for various diseases—covering kidney, hematological, cardiovascular, endocrine, genitourinary, skeletal, infectious, oncological, and pediatric conditions—along with medical supplies, cosmeceuticals, nutritional supplements, and beauty products. The company also provides advanced medical equipment, including computed radiography, ultrasound, digital mammography, X-ray, and 3D medical image processing systems, as well as laboratory information systems. Additionally, Berli Jucker engages in providing ingredients for the bakery, food, nutraceutical, and cosmetic sectors, alongside industrial chemicals and refrigerants. Its service capabilities are extensive, encompassing logistics management with warehousing, transportation, customs brokerage, and freight forwarding. The company also operates an e-commerce platform and offers consulting, design, installation, and post-sales support for industrial cranes, solar rooftop systems, and weighing control systems.